CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
Carregando...
Citações na Scopus
79
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
NASCIMENTO, Raimundo M.
COELHO, George L. L. M.
MILL, Jose G.
Citação
BMC MEDICAL GENETICS, v.12, article ID 13, 7p, 2011
Resumo
Background: Recent studies have reported the clinical importance of CYP2C19 and ABCB1 polymorphisms in an individualized approach to clopidogrel treatment. The aims of this study were to evaluate the frequencies of CYP2C19 and ABCB1 polymorphisms and to identify the clopidogrel-predicted metabolic phenotypes according to ethnic groups in a sample of individuals representative of a highly admixtured population. Methods: One hundred and eighty-three Amerindians and 1,029 subjects of the general population of 4 regions of the country were included. Genotypes for the ABCB1c.C3435T (rs1045642), CYP2C19*2 (rs4244285), CYP2C19*3 (rs4986893), CYP2C19*4 (rs28399504), CYP2C19*5 (rs56337013), and CYP2C19*17 (rs12248560) polymorphisms were detected by polymerase chain reaction followed by high resolution melting analysis. The CYP2C19*3, CYP2C19*4 and CYP2C19*5 variants were genotyped in a subsample of subjects (300 samples randomly selected). Results: The CYP2C19*3 and CYP2C19*5 variant alleles were not detected and the CYP2C19*4 variant allele presented a frequency of 0.3%. The allelic frequencies for the ABCB1c.C3435T, CYP2C19*2 and CYP2C19*17 polymorphisms were differently distributed according to ethnicity: Amerindian (51.4%, 10.4%, 15.8%); Caucasian descent (43.2%, 16.9%, 18.0%); Mulatto (35.9%, 16.5%, 21.3%); and African descent (32.8%, 20.2%, 26.3%) individuals, respectively. As a result, self-referred ethnicity was able to predict significantly different clopidogrel-predicted metabolic phenotypes prevalence even for a highly admixtured population. Conclusion: Our findings indicate the existence of inter-ethnic differences in the ABCB1 and CYP2C19 variant allele frequencies in the Brazilian general population plus Amerindians. This information could help in stratifying individuals from this population regarding clopidogrel-predicted metabolic phenotypes and design more cost-effective programs towards individualization of clopidogrel therapy.
Palavras-chave
Referências
- ALVIM RO, LIPIDS HLTH DIS, V9, P128
- Ramsjo M, 2010, EUR J CLIN PHARMACOL, V66, P871, DOI 10.1007/s00228-010-0835-0
- Sugimoto K, 2008, BRIT J CLIN PHARMACO, V65, P437, DOI 10.1111/j.1365-2125.2007.03057.x
- Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397
- Geisler T, 2008, PHARMACOGENOMICS, V9, P1251, DOI 10.2217/14622416.9.9.1251
- Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171
- Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041
- Bernal ML, 2003, THER DRUG MONIT, V25, P107, DOI 10.1097/00007691-200302000-00016
- Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002
- Gladding P, 2008, JACC-CARDIOVASC INTE, V1, P620, DOI 10.1016/j.jcin.2008.09.008
- MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
- Chang M, 1995, PHARMACOGENETICS, V5, P358, DOI 10.1097/00008571-199512000-00004
- Scordo MG, 2004, PHARMACOL RES, V50, P195, DOI 10.1016/j.phrs.2004.01.004
- Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227
- Makdisse M, 2008, ARQ BRAS CARDIOL, V91, P370
- Ragia G, 2009, PHARMACOGENOMICS, V10, P43, DOI 10.2217/14622416.10.1.43
- Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005
- Aynacioglu AS, 1999, CLIN PHARMACOL THER, V66, P185, DOI 10.1053/cp.1999.v66.100072001
- Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0
- Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007
- Goldstein JA, 1997, PHARMACOGENETICS, V7, P59, DOI 10.1097/00008571-199702000-00008
- Kazui M, DRUG METAB DISPOS, V38, P92
- Li YH, 2006, SWISS MED WKLY, V136, P377
- Limdi NA, BLOOD, V115, P3827
- MICHELSON AD, NAT REV DRUG DISCOV, V9, P154
- Mrozikiewicz PM, 2007, INT J GYNECOL CANCER, V17, p728A, DOI 10.1111/j.1525-1438.2007.00821.x
- Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83
- Roberts R. L., 2002, Pharmacogenomics Journal, V2, P191, DOI 10.1038/sj.tpj.6500099
- ROSS KA, J HUM GENET, V55, P582
- SANTOS DG, BMC MED GENET, V11, P89
- SANTOS PC, BRAZ J MED BIOL RES, V43, P107
- SIBBING D, CIRCULATION, V121, P512
- Steinhubl SR, CIRCULATION, V121, P481
- TRENK D, 2008, J AM COLL CARDIOL A, V51, pA226